Abstract
The financial reporting treatment of R&D expenditures can have important implications for firms’ strategic investment in R&D. Yet, financial reporting issues have been largely neglected in the R&D management literature. In this study, we first hypothesise that firms’ capitalisation of development expenditures subsequent to the mandatory adoption of IAS 38 (International Accounting Standard 38: Intangible Assets) is positively and significantly impacted by a measure of R&D programme success. Our empirical findings–based on a pan-European sample of firms–reveal strong support for this prediction. Our findings also offer support for our second hypothesis which predicts that capitalisation of development expenditures in conjunction with an evaluation of R&D programme success has a positive and significant impact on growth in shareholder value. Consequently, our work suggests that an important challenge for R&D professionals within firms is to develop improved measures of R&D success and to communicate this information to senior executives.
| Original language | English |
|---|---|
| Pages (from-to) | 15-30 |
| Number of pages | 16 |
| Journal | Technology Analysis and Strategic Management |
| Volume | 30 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2 Jan 2018 |
| Externally published | Yes |
Keywords
- capitalisation
- financial reporting
- income statement
- R&D investment
- statement of financial position
Fingerprint
Dive into the research topics of 'The impact of R&D programme success on the decision to capitalise development expenditures in European firms'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver